Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial

作者：Stephen A. Harrison, Juan P. Frías, Guy Neff, Gary A. Abrams, K. Lucas, William Sánchez, Sudhanshu Gogia, Muhammed Y Sheikh, Cynthia Behling, Pierre Bédossa, Lan Shao, Doreen Chan, Erica Fong, Brittany de Temple, Reshma Shringarpure, Erik J. Tillman, Tim Rolph, Andrew Cheng, Kitty Yale · 发表于：˜The œLancet. Gastroenterology & hepatology · 年份：2023 · DOI：10.1016/s2468-1253(23)00272-8 · 被引用次数：255 · 研究领域：Fibroblast Growth Factor Research、Liver Disease Diagnosis and Treatment、Liver physiology and pathology